
Sign up to save your podcasts
Or


After a brief hiatus, my stock dissection series continues with Innoviva, a company with a portfolio of royalties and other healthcare assets.
By Dr.Viveta Lobo5
88 ratings
After a brief hiatus, my stock dissection series continues with Innoviva, a company with a portfolio of royalties and other healthcare assets.